Riskpilot← Back to searchSign inGet full accessANKRON HOLDING AB
ABActiveOrg 5591931331Adelgatan 21Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
-103% vs 2023
Equity ratio
98.7%
Financial strength
Net profit 2024
SEK 26,2M
+326% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -361K | -103% |
| Net profit | SEK 26,2M | +326% |
| Total assets | SEK 70,9M | +54% |
| Equity | SEK 70M | +60% |
| Employees | 0 | — |
Legal name
ANKRON HOLDING AB
Org number
5591931331
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31 januari 2019
Share capital
SEK 1 000 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Wiest, Egon Wiest, Marie Ann-Charlotte
Company purpose
Aktiebolaget skall direkt eller indirekt, via dotterbolag, bedriva utveckling, produktion och försäljning av medicinskt utrustning, äga och förvalta fast och lös egendom samt idka annan härmed förenlig verksamhet.
Address
Adelgatan 21
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −189 | −5 | −280 | −178 | −361 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −189 | −5 | −280 | −178 | −361 |
| Net financials | 18 452 | 10 970 | 5 715 | 6 338 | 26 564 |
| Profit before tax | 18 263 | 10 965 | 5 435 | 6 160 | 26 203 |
| Tax | −0 | −0 | −0 | −5 | −9 |
| Net profit | 18 263 | 10 965 | 5 435 | 6 155 | 26 194 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23 812 | 54 866 | 95 565 | 46 165 | 70 871 |
| Equity | 21 230 | 32 195 | 37 630 | 43 785 | 69 978 |
| Long-term debt | 2 512 | 823 | 57 862 | 2 310 | 823 |
| Short-term debt | 70 | 21 848 | 73 | 70 | 70 |
| Total debt | 2 582 | 22 671 | 57 935 | 2 380 | 893 |
EBITDA margin
-36100000.0%
This company
15.8%
Market median
-228481113% vs market
20202024
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
20202024
Return on equity
37.4%
This company
18.4%
Market median
+103% vs market
20202024
Net profit margin
2619400000.0%
This company
8.1%
Market median
+32338271505% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ML | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ANKRON HOLDING AB (this company)
Ewimed Austria GmbhEwimed Danmark A/SFenik AgEwicare KftEwimed Switzerland AgEwimed GmbhEwimed Hungary KftEWIMED AUSTRIA GMBHEWIMED HUNGARY KFTEWIMED SWITZERLAND AGEWICARE KFTEWIMED DANMARK A/SEWIMED GMBHBoard members of ANKRON HOLDING AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats-Åke Lennart Andersson | Audit | 0 companies |
| Egon Edgar Wiest | Chairman | 0 companies |
| Niklas Erik Wiest | Board of Directors | 0 companies |
| Marie Ann-Charlotte Wiest | Board of Directors | 0 companies |
| Felix Nils Wiest | Board of Directors | 0 companies |